Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer

<table><i>Schematic TLR Structure. </i>TLRs are typically transmembrane receptors present in cellular or endosomal membranes, characterized by a leucine-rich pathogen-recognition domain and a toll-interleukin 1 receptor (TIR) signal transduction domain.</table>

International Scholarly Research Notices

fig1

Figure 1

Figure 1: Toll-Like Receptors as Novel Therapeutic Targets for Ovarian Cancer 